Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Health Tech
  • Biotechnology
  • AI
  • IoT
About
Codon Capital is a San Francisco-based biotech venture capital firm investing in Series A biotech companies for breakthrough therapeutics and synthetic biology solutions.
Min check size
$1M
Max check size
$20M
Fund size
NPS

Investment Thesis

They Focus on early stage investments in life sciences and technology companies, aiming to support innovation and development in these sectors.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a strong background in technology and healthcare, the fund manager has successfully completed over 30 deals across various stages of investment, emphasizing an operator-first approach. Their strategic focus on high-growth companies in North America has facilitated notable exits, demonstrating a keen ability to identify and capitalize on emerging trends. Leveraging a data-driven methodology, they have built a diverse portfolio that reflects their deep understanding of market dynamics and operational excellence. This blend of experience and insight positions them as a formidable player in the investment landscape.

Codon Capital Contacts Information

Primary contact

Team

Karl Handelsman

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp